FETAL AND ENVIRONMENTAL BASIS OF PARKINSON'S DISEASE
FETAL AND ENVIRONMENTAL BASIS OF PARKINSON'S DISEASE
批准号:
7230013
负责人:
CLIVEL G. CHARLTON
金额:
$15.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-03 至 2010-02-28
关键词:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine1-Methyl-4-phenylpyridiniumAdolescentAdultAgeAnatomyBasal GangliaBiochemistryBiologicalBirthChemicalsConditionDNADegenerative DisorderDopamineEmbryoEpigenetic ProcessExposure toFetusFormaldehydeFormic AcidsGoalsInterventionJuvenile Parkinson DiseaseLeadLifeLongevityMelanocytic nevusMethanolMethionineMethylationMitoticModelingMole the mammalMolecularMotorMotor ActivityMusNatureNeuronsNumbersOutcomeParkinson DiseasePatient currently pregnantPerinatal ExposurePhenotypePoisonPopulationPregnancyResearch PersonnelRodentStagingStressSymptomsSystemTestingTissuesToxic effectToxinTyrosine 3-Monooxygenaseage relatedbasecritical developmental perioddaydopaminergic neuronearly onsetexpectationfetalformic acidin uteroneurogenesisnigrostriatumprecursor cellpreventprogramspupresiliencetherapy developmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This study will test the proposition that toxic substances are involved in the cause of idiopathic Parkinson's disease (PD) by inducing, early in life, a less resilient but functional set of nigrostriatal (IMS) dopamine (DA) neurons that cannot withstand the stress placed on them later in life. Two stages of afflictions are therefore involved. The 1st is a predisposing, susceptible, vulnerable or sensitizing stage, occurring early in life, causing mostly epigenetic changes that impair the phenotype and/or reduce the number of the NS DA neurons. The 2nd, precipitating/inducing stage occurs when age-related wear-and-tear or other interventions damage the already susceptible NS DA neurons and precipitate the symptoms of PD. This hypothesis may explain the age-relatedness and sporadic nature o. PD. It may also explain juvenile (early onset) and adult onset PD, for the simple reason that for juvenile PD the 1st/susceptible stage will be more severe and is closer to threshold. Accordingly, the 2nd/inducing stage, of a constant intensity, will precipitate PD at an earlier age. The specific aims are: (1). To induce the 1st stage by administering methanol (MeOH) or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to pregnant mice during the vulnerable period of the differentiation/neurogenesis of the NS DA neurons of the fetuses (about gestation days 8-12). The intent is to cause subtle or subthreshold changes to the NS DA neurons of the offsprings without impairing motor functions. (2).To induce the 2nd or precipitating stage in the mature MeOH-or MPTP-treated offsprings by increasing biological methylation via S-adenosyl-L-methionine (SAM) or challenging with MPTP. These will cause further or threshold level harm to the NS DA neurons. MPTP is a precursor for the toxin, 1-methyl-4-phenylpyridinium that targeted the NS DA neurons and is fetotoxic. MeOH is an embryo-toxin (Rogers and Mole, 1997), causes basal ganglia toxicity (Guggenhein et al, 1971; Dewitt and Martin 1988; Ley and Gali 1983; Mozaz et al, 1991; Aziz et al, 2002), covalently reacts with DNA (Chung et al, 2004) and reduces total DNA (Abbot et al, 1994). It freely crosses tissue barriers and it is a precursor for formaldehyde and formic acid. The functions, anatomy and biochemistry of the basal ganglia will be studied to assess the phenotypic changes associated with the sensitization stage induced in utero as well as to verify the precipitated PD-like changes. A new model for PD may be identified and the results may lead to the development of interventions to prevent or delay similar toxicities. The approaches will find utility in the study of other degenerative disorders by focusing on other neuronal groups.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.neuroscience.2010.04.080
发表时间:
2010-09-01
期刊:
NEUROSCIENCE
影响因子:
3.3
作者:
[Muthian, G., Mackey, V., King, J., Charlton, C. G.]
通讯作者:
Charlton, C. G.
Methamphetamine Research Program at Meharry Medical College
-
批准号:8731351
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2014
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
Methamphetamine Research Program at Meharry Medical College
-
批准号:8982228
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2014
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
L-DOPA OVERLOAD: MECHANISMS FOR THE SIDE EFFECTS.
-
批准号:7827511
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2006
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
L-DOPA OVERLOAD: MECHANISMS FOR THE SIDE EFFECTS.
-
批准号:7391111
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2006
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
L-DOPA OVERLOAD: MECHANISMS FOR THE SIDE EFFECTS.
-
批准号:7047532
-
项目类别:
-
资助金额:$20.37万
-
财政年份:2006
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
FETAL AND ENVIRONMENTAL BASIS OF PARKINSON'S DISEASE
-
批准号:7046534
-
项目类别:
-
资助金额:$19.64万
-
财政年份:2006
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
L-DOPA OVERLOAD: MECHANISMS FOR THE SIDE EFFECTS
-
批准号:7194146
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2006
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
L-DOPA OVERLOAD: MECHANISMS FOR THE SIDE EFFECTS.
-
批准号:7578265
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2006
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
L-DOPA OVERLOAD: MECHANISMS FOR THE SIDE EFFECTS.
-
批准号:7777250
-
项目类别:
-
资助金额:$33.36万
-
财政年份:2006
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
"Microscopy and Immunohistochemistry Core"
-
批准号:7125328
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2005
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
SNRP PROJECT AT MEHARRY MEDICAL COLLEGE
-
批准号:6803819
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2000
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
SNRP Project at Meharry Medical College
-
批准号:7931917
-
项目类别:
-
资助金额:$94.5万
-
财政年份:2000
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
SNRP PROJECT AT MEHARRY MEDICAL COLLEGE
-
批准号:6663203
-
项目类别:
-
资助金额:$104.91万
-
财政年份:2000
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
SNRP Project at Meharry Medical College
-
批准号:7690875
-
项目类别:
-
资助金额:$124.8万
-
财政年份:2000
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
SNRP PROJECT AT MEHARRY MEDICAL COLLEGE
-
批准号:6529672
-
项目类别:
-
资助金额:$105.56万
-
财政年份:2000
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
PARKINSONISM--A METHYL-DONOR ACTION FOR MPP+
-
批准号:2269105
-
项目类别:
-
资助金额:$11.92万
-
财政年份:1993
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
PARKINSONISM AND MPP+ --A METHYL-DONOR ACTION FOR MPP+
-
批准号:3418110
-
项目类别:
-
资助金额:$13.06万
-
财政年份:1993
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
PARKINSONISM--A METHYL-DONOR ACTION FOR MPP+
-
批准号:2269104
-
项目类别:
-
资助金额:$11.46万
-
财政年份:1993
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
PARKINSONISM--A METHYL-DONOR ACTION FOR MPP+
-
批准号:3418111
-
项目类别:
-
资助金额:$12.56万
-
财政年份:1993
-
负责人:CLIVEL G. CHARLTON
-
依托单位:
EXCESS BIOLOGICAL METHYLATION AND PARKINSONS DISEASE
-
批准号:3414940
-
项目类别:
-
资助金额:$1.45万
-
财政年份:1992
-
负责人:CLIVEL G. CHARLTON
-
依托单位: